Novel rapid-acting glutamatergic modulators: targeting the synaptic plasticity in depression

YT Wang, XL Wang, ST Feng, NH Chen… - Pharmacological …, 2021 - Elsevier
Major depressive disorder (MDD) is severely prevalent, and conventional monoaminergic
antidepressants gradually exhibit low therapeutic efficiency, especially for patients with …
被引用次数：37 相关文章

Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.

YT Wang, XL Wang, ST Feng, NH Chen… - Pharmacological …, 2021 - europepmc.org
Major depressive disorder (MDD) is severely prevalent, and conventional monoaminergic
antidepressants gradually exhibit low therapeutic efficiency, especially for patients with …

Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression

YT Wang, XL Wang, ST Feng… - Pharmacological …, 2021 - pubmed.ncbi.nlm.nih.gov
Major depressive disorder (MDD) is severely prevalent, and conventional monoaminergic
antidepressants gradually exhibit low therapeutic efficiency, especially for patients with …